Fig. 1: Delayed retinal vascular maturation following anti-VEGF therapy requires surveillance.
From: 80 Years of vision: preventing blindness from retinopathy of prematurity
Left eye of a child with type 1 ROP who had undergone two anti-VEGF injections at an outside hospital as an infant and did not receive follow-up with fluorescein angiography and laser until 18 months of age, disclosing continued neovascular activity with severe macular distortion. The fellow (right) eye of the child had also received three anti-VEGF injections at an outside hospital and was phthisical.
